You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
|
|---|---|
| Published in |
Cardiovascular Diabetology, September 2022
|
| DOI | 10.1186/s12933-022-01604-7 |
| Pubmed ID | |
| Authors |
Michael A. Nauck, David A. D‘Alessio |
X Demographics
The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 20% |
| Spain | 8 | 16% |
| Mexico | 4 | 8% |
| India | 3 | 6% |
| United Kingdom | 2 | 4% |
| Paraguay | 1 | 2% |
| Korea, Republic of | 1 | 2% |
| Dominican Republic | 1 | 2% |
| Brazil | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 17 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 53% |
| Scientists | 13 | 27% |
| Practitioners (doctors, other healthcare professionals) | 9 | 18% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 167 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 14 | 8% |
| Researcher | 14 | 8% |
| Student > Bachelor | 12 | 7% |
| Student > Ph. D. Student | 9 | 5% |
| Other | 9 | 5% |
| Other | 22 | 13% |
| Unknown | 87 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 14% |
| Unspecified | 14 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Neuroscience | 5 | 3% |
| Other | 15 | 9% |
| Unknown | 94 | 56% |
Attention Score in Context
This research output has an Altmetric Attention Score of 65. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#668,749
of 25,660,026 outputs
Outputs from Cardiovascular Diabetology
#28
of 1,684 outputs
Outputs of similar age
#16,082
of 430,891 outputs
Outputs of similar age from Cardiovascular Diabetology
#3
of 55 outputs
Altmetric has tracked 25,660,026 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,684 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,891 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.